The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin.
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Because monoclonal antibodies (mAbs) directed against alpha4-integrin and VCAM-1 inhibit the development of experimental autoimmune encephalomyelitis (EAE) in vivo, it has been concluded that the successful therapeutic effect is due to interference with alpha4beta1/VCAM-1-mediated interaction of autoaggressive T cells with the blood-brain barrier. A possible role for alpha4beta7-integrin, or interference with other T cell mediated events during the pathogenesis of EAE, has not been considered. We have compared the effects of mAb therapy on the development of EAE in the SJL/N mouse, using a large panel of mAbs directed against alpha4, beta7, the alpha4beta7-heterodimer, and against VCAM-1. Although encephalitogenic T cells express both alpha4-integrins, mAbs directed against the alpha4beta7-heterodimer or against the beta7-subunit did not interfere with the development of EAE. In contrast, mAbs directed against alpha4 and VCAM-1 inhibited or diminished clinical or histopathological signs of EAE. Our data demonstrate for the first time that alpha4beta7 is not essential for the development of EAE. Furthermore, our in vitro studies suggest that the therapeutic effect of anti-alpha4-treatment of EAE might also be caused by inhibition of antigen-specific T cell proliferation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, a neutralizing antibody against α4-integrin, which pairs with β1-integrin to form very late antigen-4 (VLA-4), which mediates leukocyte adhesion to the inflamed endothelium via VCAM-1 (22), did not reduce LPS-induced vascular leakage (SI Appendix, Fig. S12).”
From Targeting β1-integrin inhibits vascular leakage in endotoxemia (2018) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 6,929 · cited 1×
“on the surface of leukocytes and endothelial cells are actively involved in the recruitment of specific leukocyte subsets into different tissues (1, 2).”
BackgroundLeukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity
Butcher, E. C. (1991) · Cell · doi:10.1016/0092-8674(91)90279-8 · Cited by 2,761 · cited 1×
“on the surface of leukocytes and endothelial cells are actively involved in the recruitment of specific leukocyte subsets into different tissues (1, 2).”
BackgroundPrevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin
Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L., & Karin, N. (1992) · Nature · doi:10.1038/356063a0 · Cited by 1,737
Baron, J. L., Madri, J. A., Ruddle, N. H., Hashim, G., & Janeway, C. A. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.57 · Cited by 835 · cited 6×
“2, although a poor inhibitor of a 4-integrin–mediated lymphocyte homing in vivo (18), has been shown to interfere with the development of EAE (17).”
BackgroundMethodResultInfluentialStamper, H. B., & Woodruff, J. J. (1976) · The Journal of experimental medicine · doi:10.1084/jem.144.3.828 · Cited by 670 · cited 1×
“Evidence for the functional importance of cerebral endothelial expression of ICAM-1 and VCAM-1 is provided by studies using a modified Stamper-Woodruff frozen section assay (10).”
MethodRole of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo.
Hamann, A., Andrew, D. P., Jablonski-Westrich, D., Holzmann, B., & Butcher, E. C. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.7.3282 · Cited by 628 · cited 3×
“However, the very same mAbs have been demonstrated to successfully inhibit a4b7mediated lymphocyte homing into mucosal lymph nodes in healthy animals (18) and to inhibit spontaneous autoimmune diabetes (31).”
BackgroundEvidence for a role of the integrin VLA-4 in lympho-hemopoiesis.
Miyake, K., Weissman, I. L., Greenberger, J. S., & Kincade, P. W. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.599 · Cited by 589
Holzmann, B., McIntyre, B. W., & Weissman, I. L. (1989) · Cell · doi:10.1016/0092-8674(89)90981-1 · Cited by 479
Jalkanen, S. T., Bargatze, R. F., Herron, L. R., & Butcher, E. C. (1986) · European Journal of Immunology · doi:10.1002/eji.1830161003 · Cited by 416
Miyake, K., Medina, K., Ishihara, K., Kimoto, M., Auerbach, R., & Kincade, P. W. (1991) · The Journal of cell biology · doi:10.1083/jcb.114.3.557 · Cited by 381
Cited by
Items 101–200 of 207
Yu, C., Lee, Y. S., Mahdi, R. M., Surendran, N., & Egwuagu, C. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029742 · Cited by 53
“a4b1 and a4b7 integrins have been implicated in chronic demyelinating diseases [26,27,28,29].”
BackgroundMerz, J., Albrecht, P., von Garlen, S., Ahmed, I. A., Dimanski, D., Wolf, D., Hilgendorf, I., Härdtner, C., Grotius, K., Willecke, F., et al. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0702-1 · Cited by 50
Qing, Z., Sándor, M., Radvány, Z., Sewell, D. L., Falus, A., Potthoff, D., Müller, W. A., & Fábry, Z. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.798 · Cited by 49
“Antibodies to VLA-4 can prevent EAE even when the treatment started 2 days after adoptive transfer of encephalitogenic T cells (29) or just before the onset of clinical signs (26).”
BackgroundNorman, M. U., James, W. G., & Hickey, M. J. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107796 · Cited by 48
Case histories, magic bullets and the state of drug discovery
Drews, J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2084 · Cited by 57
“, an animal model of multiple sclerosis, and even reversed paralysis that had occurred after the onset of the diseas”
BackgroundNiu, X., Sang, H., & Wang, J. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108560 · Cited by 46
Anti-Integrin Therapy for Multiple Sclerosis
Kawamoto, E., Nakahashi, S., Okamoto, T., Imai, H., & Shimaoka, M. (2012) · Autoimmune Diseases · doi:10.1155/2012/357101 · Cited by 48
A Comparative Perspective on Wnt/β-Catenin Signalling in Cell Fate Determination
Garcin, C. L., & Habib, S. J. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-53150-2_15 · Cited by 43
Dieterich, L. C., Kapaklikaya, K., Cetintas, T., Proulx, S. T., Commerford, C. D., Ikenberg, K., Bachmann, S. B., Scholl, J., & Detmar, M. J. (2019) · International Journal of Cancer · doi:10.1002/ijc.32594 · Cited by 40
Mindur, J. E., Ito, N., Dhib-Jalbut, S. S., & Ito, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099068 · Cited by 41
“Preliminary experiments discovered that antibodies against the a-chain of VLA-4 could successfully inhibit pathogenic T cell and monocyte entry into the CNS, resulting in the prevention of EAE [2–5].”
BackgroundTang, M. T., Keir, M. E., Erickson, R., Stefanich, E. G., Fuh, F. K., Ramirez‐Montagut, T., McBride, J., & Danilenko, D. M. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14631 · Cited by 42
“In addition, in other models of chronic CNS inflammation, CD4 memory T-lymphocyte infiltrates in the CNS do not express a4b7, a6 or aE integrin but instead, strongly express a4b1.(59,60) Furthermore, MAdCAM-1 (the ligand for a4b7) is not expressed on cerebral endothelial vessels, perivascular tissue, the meninges and…”
BackgroundBlocking Development of a CD8+ T Cell Response by Targeting Lymphatic Recruitment of APC
Teoh, D., Johnson, L. A., Hanke, T., McMichael, A. J., & Jackson, D. G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803661 · Cited by 39
Amos, C. L., Romero, I. A., Schültze, C., Rousell, J., Pearson, J. D., Greenwood, J., & Adamson, P. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.5.810 · Cited by 38
Kuhbandner, K., Hammer, A., Haase, S., Terbrack, E., Hoffmann, A., Schippers, A., Wagner, N., Hussain, R. Z., Miller-Little, W. A., Koh, A. Y., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00903 · Cited by 41
Sandy, A. R., Stoolman, J. S., Malott, K. F., Pongtornpipat, P., Segal, B. M., & Maillard, I. P. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301116 · Cited by 40
Alt, C., Duvefelt, K., Franzén, B., Yang, Y., & Engelhardt, B. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00094.x · Cited by 37
“We and others have demonstrated the latter to be involved in the recruitment of encephalitogenic T-cells into the CNS in vivo (19, 37, 56, 60).”
BackgroundSelf-citationJahromi, N. H., Tardent, H., Enzmann, G. U., Deutsch, U., Kawakami, N., Bittner, S., Vestweber, D., Zipp, F., Stein, J. V., & Engelhardt, B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00406 · Cited by 37
“MJ7/18 was purified endotoxin-free from hybridoma culture supernatants exactly as described (42) and conjugated with Alexa Fluor 594 labeling kit (Invitrogen, Molecular probes, USA, Catalog number: A10239) according to the manufacturers instructions.”
MethodSelf-citationJames, W. G., Hutchinson, P. E., Bullard, D. C., & Hickey, M. J. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03056.x · Cited by 36
Regulation of Immune Response and Inflammatory Reactions against Viral Infection by VCAM-1
Ou, R., Zhang, M., Huang, L., Flavell, R. A., Koni, P. A., & Moskophidis, D. (2008) · Journal of Virology · doi:10.1128/jvi.02191-07 · Cited by 38
Klotz, L., Diehl, L., Dani, I., Neumann, H., von Oppen, N., Dolf, A., Endl, E., Klockgether, T., Engelhardt, B., & Knolle, P. A. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.07.017 · Cited by 41
Self-citationDöring, A., Pfeiffer, F., Meier, M., Dehouck, B., Tauber, S., Deutsch, U., & Engelhardt, B. (2011) · European Journal of Immunology · doi:10.1002/eji.201040912 · Cited by 39
Self-citationNeuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications
Bittner, S., & Wiendl, H. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0405-3 · Cited by 35
Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis
Tietz, S., Périnat, T., Greene, G., Enzmann, G. U., Deutsch, U., Adams, R. H., Imhof, B. A., Aurrand‐Lions, M., & Engelhardt, B. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.06.014 · Cited by 31
Self-citationAntisense therapy of MAdCAM-1 for trinitrobenzenesulfonic acid-induced murine colitis
Goto, A., Arimura, Y., Shinomura, Y., Imai, K., & Hinoda, Y. (2006) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200608000-00013 · Cited by 31
“In autoimmune encephalomyelitis, blockade of a4 integrins is more effective than blockade of its counterligand, VCAM-1.(9) Because natalizumab blocks the a4b1/VCAM-1 pathway, which regulates peripheral T cell trafficking including in the brain and is an essential constituent of the blood-brain barrier,(10) natalizumab…”
BackgroundWaidmann, M., Allemand, Y., Lehmann, J., di Genaro, S., Bücheler, N., Hamann, A., & Autenrieth, I. B. (2002) · Gut · doi:10.1136/gut.50.2.170 · Cited by 31
Jurisic, G., Sundberg, J. P., Bleich, A., Leiter, E. H., Broman, K. W., Büchler, G., Alley, L., Vestweber, D., & Detmar, M. J. (2010) · Genes and Immunity · doi:10.1038/gene.2010.4 · Cited by 28
Self-citationDoerck, S., Göbel, K., Weise, G., Schneider‐Hohendorf, T., Reinhardt, M., Hauff, P., Schwab, N., Linker, R. A., Mäurer, M., Meuth, S. G., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015478 · Cited by 28
“Thereby, especially the interaction between the alpha4beta1 integrin very late antigen (VLA)-4 and leukocyte function associated antigen (LFA)-1 with their respective immunoglobulin-like ligands vascular cell adhesion molecule (VCAM)-I and intercellular adhesion molecule (ICAM)-I were shown to be essential for leukocy…”
ICAM-1null C57BL/6 Mice Are Not Protected from Experimental Ischemic Stroke
Enzmann, G. U., Pavlidou, S., Vaas, M., Klohs, J., & Engelhardt, B. (2018) · Translational Stroke Research · doi:10.1007/s12975-018-0612-4 · Cited by 29
“12) [32], rat anti-mouse PECAM-1 (Mec13.”
MethodSelf-citationIFN-γ is a therapeutic target in paraneoplastic cerebellar degeneration
Yshii, L., Pignolet, B., Mauré, E., Pierau, M., Brunner-Weinzierl, M. C., Hartley, O., Bauer, J., & Liblau, R. (2019) · JCI Insight · doi:10.1172/jci.insight.127001 · Cited by 28
“Immune cell infiltration into the CNS can be prevented by blocking α4β1 integrin in murine model of multiple sclerosis (MS) (28, 29).”
BackgroundSAP suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice
Ji, Z., Ke, Z., & Geng, J. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.51 · Cited by 28
Functional knockdown of VCAM-1 at the posttranslational level with ER retained antibodies
Strebe, N., Guse, A., Schüngel, M., Schirrmann, T., Hafner, M., Jostock, T., Hust, M., Müller, W., & Dübel, S. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.10.012 · Cited by 26
“The blocking ability of antibody 6C7.1 was described before ( Engelhardt et al., 1998 ).”
BackgroundMethodInfluentialWethmar, K., Helmus, Y., Lühn, K., Jones, C., Laskowska, A. K., Varga, G., Grabbe, S., Lyck, R., Engelhardt, B., Bixel, M. G., et al. (2006) · European Journal of Immunology · doi:10.1002/eji.200526311 · Cited by 26
Self-citationRole of glucocorticoids on T cell recruitment across the blood-brain barrier
Engelhardt, B. (2000) · Zeitschrift für Rheumatologie · doi:10.1007/s003930070012 · Cited by 26
Self-citationMyers, K. J., Witchell, D. R., Graham, M. J., Koo, S., Butler, M., & Condon, T. P. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.10.029 · Cited by 24
“However, EAE development in SJL mice has been shown to depend on a4h1 rather than a4h7 (Engelhardt et al., 1998).”
BackgroundNoseworthy, J. H., & Kirkpatrick, P. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1637 · Cited by 24
Neuroinflammation in neurodegenerative diseases: Focusing on the mediation of T lymphocytes
Li, K., Chen, R., Wang, R., Fan, W., Zhao, N., Yang, Z., & Yan, J. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01539 · Cited by 24
“The primary function of Itgα4 is to attract inflammatory cells to the CNS (Engelhardt et al., 1998).”
Uboldi, C., Döring, A., Alt, C., Estess, P., Siegelman, M. H., & Engelhardt, B. (2008) · European Journal of Immunology · doi:10.1002/eji.200838209 · Cited by 22
Self-citationStavropoulos, F., Georgiou, E., Sargiannidou, I., & Kleopa, K. A. (2021) · Pharmaceuticals · doi:10.3390/ph14070621 · Cited by 21
“Natalizumab used in MS treatment blocks the α4β1/VCAM-1 interaction which is required for EAE development [34], thus preventing the migration of leukocytes through the BBB into the inflamed CNS [31,33].”
BackgroundDeckert, M., Lütjen, S., Leuker, C., Kwok, L., Strack, A., Müller, W., Wagner, N., & Schlüter, D. (2003) · European Journal of Immunology · doi:10.1002/eji.200322826 · Cited by 21
Johann, L., Soldati, S. G., Müller, K., Lampe, J., Marini, F., Klein, M., Schramm, E., Ries, N., Schelmbauer, C., Palagi, I., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci168314 · Cited by 21
Self-citationGraesser, D., Solowiej, A., Bruckner, M., Osterweil, E. K., Juedes, A. E., Davis, S., Ruddle, N. H., Engelhardt, B., & Madri, J. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200213595 · Cited by 20
Self-citationPhenotypes of T cells infiltrating the eyes in autoimmune anterior uveitis associated with EAE.
Zhang, X., Jiang, S., Mańczak, M., Sugden, B., & Adamus, G. (2002) · PubMed · Cited by 18
Targeting Leukocyte Trafficking in Inflammatory Bowel Disease
Wyatt, N. J., Speight, A., Stewart, C. J., Kirby, J. A., & Lamb, C. A. (2021) · BioDrugs · doi:10.1007/s40259-021-00496-5 · Cited by 18
Minagar, A., Carpenter, A. C., & Alexander, J. S. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)79001-3 · Cited by 16
Blatt, N. L., Хайбуллин, Т. И., Lombardi, V. C., Rizvanov, A. A., & Khaiboullina, S. F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00683 · Cited by 17
Adhesion Molecule Targeted Therapy for Non-Infectious Uveitis
Chen, Y., Lightman, S., Eskandarpour, M., & Calder, V. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010503 · Cited by 15
“This is supported by the fact that antibodies against α4β7 heterodimer or β7-integrin fail to downregulate disease [12].”
BackgroundSpontaneous remyelination following prolonged inhibition of α4 integrin in chronic EAE
Piraino, P. S., Yednock, T. A., Messersmith, E. K., Pleiss, M. A., Freedman, S. B., Hammond, R. R., & Karlik, S. J. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.06.018 · Cited by 17
Ky, M. N., Duran, A., Hasantari, I., Bru, A., Deloire, M., Brochet, B., Ruet, A., & Schmitt, N. (2023) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200166 · Cited by 14
Vanderslice, P., Woodside, D. G., Caivano, A. R., Decker, E. R., Munsch, C. L., Sherwood, S. J., LeJeune, W. S., Miyamoto, Y., McIntyre, B. W., Tilton, R. G., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.08.114 · Cited by 14
Piraino, P. S., Yednock, T. A., Freedman, S. B., Messersmith, E. K., Pleiss, M. A., & Karlik, S. J. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1223oa · Cited by 16
Engelhardt, B., Vajkoczy, P., & Laschinger, M. (2003) · Humana Press eBooks · doi:10.1385/1-59259-419-0:83 · Cited by 14
Self-citationBiotin–NeutrAvidin Mediated Immobilization of Polymer Micro- and Nanoparticles on T Lymphocytes
Ayer, M., Burri, O., Guiet, R., Seitz, A., Kaba, E., Engelhardt, B., & Klok, H. (2021) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.1c00026 · Cited by 13
Self-citationRossi, B., Dusi, S., Angelini, G., Bani, A., Lopez, N., Bianca, V. D., Pietronigro, E. C., Zenaro, E., Zocco, C., & Constantin, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1071553 · Cited by 13
“Whereas in a model of relapsing–remitting EAE in SJL mice, blockade of b7 integrins had no effect on disease (72), inhibition of MAdCAM-1 or b7 integrins significantly interfered with disease development in a chronic EAE model in C57BL/6 mice, supporting our data obtained in the same experimental model (70, 73).”
ResultRigolio, R., Biffi, A., Oggioni, N., & Cavaletti, G. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.05.008 · Cited by 12
CD4+c-Met+Itgα4+ T cell subset promotes murine neuroinflammation
Benkhoucha, M., Tran, N. L., Bréville, G., Senoner, I., Bradfield, P. F., Papayannopoulou, T., Merkler, D., Korn, T., & Lalive, P. H. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02461-7 · Cited by 11
“Numerous studies confirmed the predominant involvement of Itgα4—vascular cell adhesion molecule (VCAM)-1 subunit—in inflammatory cell recruitment into the CNS in different EAE models [57].”
Integrin-directed antibody-based immunotherapy: focus on VLA-4
Savino, W., Chaves, B., Bonomo, A. C., & Cotta-de-Almeida, V. (2021) · Immunotherapy Advances · doi:10.1093/immadv/ltab002 · Cited by 11
Wolburg, H., Wolburg‐Buchholz, K., & Engelhardt, B. (2004) · Springer eBooks · doi:10.1007/978-3-662-05426-0_2 · Cited by 11
Self-citationFatalities in natalizumab treatment – a ‘no go’ for leukocyte recirculation approaches?
Li, Y. Y., Perez, H. D., & Zollner, T. M. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.4.489 · Cited by 11
“Adoptive transfer of activated rat T cells into severe combined immunodeficient (SCID) mice causes an accelerated recruitment of bone marrow-derived APC into the CNS, suggesting that during inflammation in EAE, bone marrow APC precursors can migrate to the CNS in response to activation signal [94].”
BackgroundInfluentialMononuclear Phagocytes at the Blood–Brain Barrier in Multiple Sclerosis
de Vries, H. E., & Dijkstra, C. D. (2004) · Elsevier eBooks · doi:10.1016/b978-012639011-7/50025-5 · Cited by 11
Antegren (Natalizumab)Ein viel versprechender neuer Ansatz für die Therapie der Multiplen Sklerose
Kümpfel, T., Heydari, N., & Hohlfeld, R. (2002) · Der Nervenarzt · doi:10.1007/s00115-002-1314-3 · Cited by 9
VCAM-1 and its functions in development and inflammatory diseases
Hyduk, S. J., & Cybulsky, M. I. (2007) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7975-9_6 · Cited by 9
Antibody to α4β7Integrin for Ulcerative Colitis
Danese, S., Rue, S. A. D. L., & Gasbarrini, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmc051937 · Cited by 8
Enzmann, G. U., Adelfio, R., Godel, A., Jahromi, N. H., Tietz, S., Burgener, S. S., Deutsch, U., Wekerle, H., Benarafa, C., & Engelhardt, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061433 · Cited by 7
“12) [41], rat anti-mouse PECAM-1 (clone Mec13.”
Self-citationAdams, J. E., Webb, M. S., Hu, X., Staunton, D. E., & Barnum, S. R. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.12.007 · Cited by 7
“However inhibition of α4 integrins, by a variety of approaches, does not completely prevent disease, due most likely to the participation of other cellular adhesion molecules in the disease process (Engelhardt et al., 1998; Kent et al., 1995; Myers et al., 2005; Yednock et al., 1992).”
BackgroundBerve, K., Michel, J., Tietz, S. M., Blatti, C., Ivan, D., Enzmann, G., Lyck, R., Deutsch, U., Locatelli, G., & Engelhardt, B. (2024) · European Journal of Immunology · doi:10.1002/eji.202350761 · Cited by 5
Self-citationPreclinical Testing of Strategies for Therapeutic Targeting of Human T-Cell Trafficking In Vivo
Coisne, C., & Engelhardt, B. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-461-6_17 · Cited by 5
Self-citationImmune Cell Trafficking in the Central Nervous System
John, B., Hunter, C. A., & Harris, T. H. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1071-7_2 · Cited by 6
Immune cell migration across the blood–brain barrier: molecular mechanisms and therapeutic targeting
Engelhardt, B. (2005) · Future Neurology · doi:10.2217/14796708.1.1.47 · Cited by 4
Self-citationSalas, J. R., Ryan, A. R., Trias, A. O., Chen, B. Y., Güemes, M., Galić, Z., Schultz, K. A., & Clark, P. M. (2024) · Immunology · doi:10.1111/imm.13885 · Cited by 3
α4-integrins: structure, function and secrets
Engelhardt, B. (2007) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7975-9_5 · Cited by 3
Self-citationInvestigation of the teratogenic potential of VLA-4 antagonist derivatives in rats
Sakurai, K., Matsuoka, T., Suzuki, C., Kinoshita, J., Takayama, G., & Shimomura, K. (2014) · Reproductive Toxicology · doi:10.1016/j.reprotox.2014.08.003 · Cited by 3
“Also, VLA-4 antagonists, including monoclonal antibodies for 4 subunits, are reported to have efficacy in the treatment of muliple sclerosis [3], spinal cord injury [4], and epilepsy [5].”
BackgroundRegulation of the Inflammatory Response in Brain
Stenzel, W., & Alber, G. (2007) · Springer eBooks · doi:10.1007/978-0-387-30398-7_10 · Cited by 3
Engelhardt, B., Laschinger, M., & Vajkoczy, P. (2004) · Elsevier eBooks · doi:10.1016/b978-012639011-7/50007-3 · Cited by 3
Self-citationAlnawajha, A., Endharti, A. T., Santoso, S., & Santosaningsih, D. (2024) · Journal of Tropical Life Science · doi:10.11594/jtls.14.02.18 · Cited by 2
Inflammation and Regulation by Integrin Cell Adhesion Antagonists
Woodside, D. G., & Vanderslice, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813832-8.00003-0 · Cited by 5
The Blood-Brain Barrier in EAE
Engelhardt, B., & Wolburg, H. (2008) · Springer eBooks · doi:10.1007/0-387-25518-4_20 · Cited by 2
Self-citationChen, Y., Chen, Y., Zhang, Z., Tao, M., & Geng, C. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s614693 · Cited by 1
“132 While some studies show β7 deficiency or antibodies alleviate EAE, 133 others report no impact on CNS inflammation, 134,135 possibly due to model variations.”
Leukocyte Adhesion Mechanisms in Chronic Inflammatory Disease
Kubes, P., & Hickey, M. J. (2003) · Springer eBooks · doi:10.1007/978-2-8178-0761-4_3 · Cited by 1
Interactions between the immune and nervous systems
Kilpatrick, T. J., Ransohoff, R. M., & Wesselingh, S. L. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9781139195805.002 · Cited by 1
Engelhardt, B., Laschinger, M., & Vajkoczy, P. (2001) · Springer eBooks · doi:10.1007/978-1-4615-0579-2_20 · Cited by 1
Self-citationO’Sullivan, D. (2012) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.16997467 · Cited by 2
Natalizumab: Neuer Standard der Therapieeffektivität?
Vass, K. (2010) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1
ICAM-5 (Telencephalin) : a Novel Cell Adhesion Molecule
Li, T. (2001) · Helda - University of Helsinki Institutional Repository · Cited by 1
CD49d-specific Single Domain Antibodies for the Treatment of Multiple Sclerosis
Alsughayyir, J. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-6217
Bauer, M. (2008) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.9971
Lymphocyte migration to the brain
Dijkstra, I. M., & Ransohoff, R. M. (2006) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7442-x_8
“Antibody-inhibition studies [56, 61 ] and (frozen section) adhesion assays [55, 62] clearly implicated α4β1-VCAM-1 and probably also LFA-1-ICAM-1 interactions during EAE.”
BackgroundResultAutoimmune T cell - B cell interaction in experimental autoimmune encephalomyelitis
Flach, A. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4961
Mechanisms of T-Cell Migration Across the Bbb
Lyck, R., & Martinelli, R. (2011) · Future Neurology · doi:10.2217/fnl.11.18
Nitric Oxide in Experimental Allergic Encephalomyelitis
Brahmachari, S., & Pahan, K. (2008) · Springer eBooks · doi:10.1007/978-0-387-30375-8_13
Inflammatory process in immune-privileged organs.
MADEJ, J. A., Madej, J. P., & Kandefer-Gola, M. (2013) · Medycyna Weterynaryjna
Immunopathogenesis of cortical demyelination in Multiple Sclerosis
Lagumersindez-Denis, N. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5375
Leukocyte Entry into the Brain
Dorovini‐Zis, K., Wong, D. K., & Liu, K. (2015) · doi:10.1201/b18606-15
Negotiating the brain barriers: access of immune cells and pathogens into the CNS
Engelhardt, B. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9781139195805.005
Self-citationExploring Novel Therapies for Motor and Non-Motor Symptoms in a Mouse Model of Multiple Sclerosis
Benson, C. A. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r34m91s6b
Leukocyte Entry into the Brain
Dorovini‐Zis, K., Wong, D. K., & Liu, K. (2015) · CRC Press eBooks · doi:10.1201/b18606-13
Sandrock, A. W., & Rudick, R. A. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.011
Brakebusch, C. (2005) · Experimental Dermatology · doi:10.1111/j.0906-6705.2005.0323c.x
Characterization of the invasion of hematopoietic myeloid cells into the CNS during EAE
Haberl, M. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9586 · Cited by 1
Metadata
- Authors
- Engelhardt, B., Laschinger, M., Schulz, M., Samulowitz, U., Vestweber, D., & Hoch, G.
- Affiliations
- Max Planck Society (DE)
- University of Münster (DE)
- Venue
- Journal of Clinical Investigation
- Published
- 1998-12-15
- Volume
- 102
- Issue
- 12
- Pages
- 2096-2105
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC509164
- OpenAlex
- W2155492240
- Cited by
- 203
- References
- 39
- Citations by year
- 2024: 3 · 2023: 4 · 2022: 4 · 2021: 7 · 2020: 3 · 2019: 6 · 2018: 8 · 2017: 6 · 2016: 4 · 2015: 7 · 2014: 6 · 2013: 9 · 2012: 11
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- experimental autoimmune encephalomyelitis, CD49d, alpha4beta7 integrin, VCAM-1, blood-brain barrier, encephalitogenic T cells, T cell proliferation, autoimmunity, integrin heterodimers
- MeSH terms
- Animals, Antibodies, Monoclonal, Cell Adhesion, Cell Division, Cell Line, Encephalomyelitis, Autoimmune, Experimental, Female, Flow Cytometry, Immunization, Mice, Inbred Strains, Peptide Fragments, Recombinant Proteins, T-Lymphocytes, Tumor Necrosis Factor-alpha, Antigens, CD, Cell Adhesion Molecules, Integrins, Myelin Proteolipid Protein, Vascular Cell Adhesion Molecule-1, Integrin alpha4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.